Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03915912 · ClinicalTrials.gov registry record · NA
Mindfulness Meditation in Glioma Patients
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03915912 is a NA study that has completed, run by Duke University. The registered enrollment target is 17 participants.
The verdict
NCT03915912, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This pilot study is designed to determine the feasibility of providing a mindfulness meditation program to patients with newly diagnosed malignant glioma during standard of care chemoradiation. Newly diagnosed malignant glioma patients will participate in six 1-hour mindfulness sessions over the phone, followed by one 1-hour in-person mindfulness session. Patients will complete various Quality of Life questionnaires and distress measuring tools prior to initiating the mindfulness sessions, at the clinic visit following the mindfulness intervention, and \~2 months after completing the mindfulness intervention. Additionally, patients will be provided with supplemental materials including website references and guided audiotape meditations to guide their individual practice outside of the weekly guided sessions. The main objective of this study is to assess the feasibility of a mindfulness meditation intervention program, designed to mitigate the distress associated with the disease and first line treatment of patients with malignant glioma, and to determine whether it merits additional research in a subsequent trial. There are no risks associated with participation in this study.
Interventions
- BEHAVIORAL Mindfulness meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-04-11 |
| Est. Completion | 2020-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03915912
The ClinicalTrials.gov registry entry for NCT03915912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness meditation is the first listed.
NCT03915912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03915912 about?
NCT03915912 is a clinical study titled "Mindfulness Meditation in Glioma Patients". This pilot study is designed to determine the feasibility of providing a mindfulness meditation program to patients with newly diagnosed malignant glioma during standard of care chemoradiation. Newly diagnosed malignant glioma patients will participate in six 1-hour mindfulness sessions over the pho...
What is the current status of trial NCT03915912?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-04-11. Estimated completion is 2020-01-09.
What interventions are being tested in trial NCT03915912?
The interventions under investigation include: Mindfulness meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03915912?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.